Medicare Enrolled
Dr. Kristen Erickstad, MD
Rheumatology · Longview, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Erickstad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Erickstad?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Erickstad
Dr. Kristen Erickstad is a rheumatology specialist in Longview, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Erickstad performed 29,520 Medicare services across 3,230 unique beneficiaries.
Between the years covered by Open Payments, Dr. Erickstad received a total of $10,908 from 52 pharmaceutical and/or device companies across 755 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Erickstad is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 29% volume in TX
$10,908 industry payments
Medicare Practice Summary
Medicare Utilization ↗29,520
Medicare services
Top 29% in TX for rheumatology
3,230
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,109 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 13,020 | $8 | $28 |
| Denosumab injection (Prolia/Xgeva) | 10,500 | $18 | $65 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
839 | $8 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
779 | $86 | $200 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
700 | $10 | $105 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
613 | $5 | $28 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
599 | $3 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
553 | $8 | $40 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
280 | $10 | $50 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
215 | $91 | $315 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
197 | $29 | $140 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
185 | $64 | $135 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
181 | $113 | $310 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
164 | $21 | $200 |
| Rheumatoid factor level | 105 | $5 | $55 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
92 | $29 | $88 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
90 | $6 | $199 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
60 | $4 | $25 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
53 | $20 | $64 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
36 | $20 | $59 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
31 | $6 | $27 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
29 | $22 | $77 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
27 | $28 | $107 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
22 | $29 | $31 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $74 | $200 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
18 | $72 | $85 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
18 | $43 | $200 |
| X-ray of sacroiliac joint, 3 or more views An X-ray imaging test that takes three or more pictures of the joint connecting the lower spine to the hip bone. |
14 | $17 | $79 |
| Hip X-ray, 2-3 views An X-ray imaging test of the hip joint using two to three different angles to visualize the bones and surrounding structures. |
12 | $23 | $101 |
| Liver function blood test panel | 12 | $8 | $51 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
12 | $16 | $70 |
| Hepatitis C antibody test A blood test that checks for antibodies to the hepatitis C virus. This test helps determine if a person has been exposed to the virus. |
12 | $12 | $85 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
11 | $282 | $305 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
11 | $125 | $270 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
11 | $29 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
81.5% medium
17.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,908
Total received (2018-2024)
Avg $1,558/year across 7 years
Top 32% in TX for rheumatology
52
Companies
755
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,618 (97.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$289 (2.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,281
2023
$2,062
2022
$1,655
2021
$1,912
2020
$1,402
2019
$1,212
2018
$1,385
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,379
ABBVIE INC.
$879
UCB, Inc.
$787
Lilly USA, LLC
$715
PFIZER INC.
$660
AbbVie Inc.
$519
GlaxoSmithKline, LLC.
$511
Janssen Biotech, Inc.
$479
Novartis Pharmaceuticals Corporation
$434
Radius Health, Inc.
$376
AstraZeneca Pharmaceuticals LP
$343
AbbVie, Inc.
$327
E.R. Squibb & Sons, L.L.C.
$313
Genentech USA, Inc.
$280
Horizon Therapeutics plc
$198
Bayer Healthcare Pharmaceuticals Inc.
$173
Daiichi Sankyo Inc.
$163
Boehringer Ingelheim Pharmaceuticals, Inc.
$153
Celgene Corporation
$143
Novo Nordisk Inc
$107
Bayer HealthCare Pharmaceuticals Inc.
$94
SANOFI-AVENTIS U.S. LLC
$85
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$76
GENZYME CORPORATION
$74
Dynavax Technologies Corporation
$57
Merck Sharp & Dohme LLC
$52
Eisai Inc.
$48
SOBI, INC
$33
Antares Pharma, Inc.
$33
Amarin Pharma Inc.
$28
Kowa Pharmaceuticals America, Inc.
$28
Horizon Pharma plc
$27
MEDAC PHARMA, INC.
$25
Lundbeck LLC
$23
Corcept Therapeutics
$22
Itamar Medical Inc
$21
Pacira Therapeutics, Inc.
$19
Synergy Pharmaceuticals Inc
$19
Fresenius Kabi USA, LLC
$18
Astellas Pharma US Inc
$17
Pfizer Inc.
$17
Exact Sciences Corporation
$16
Mallinckrodt LLC
$16
Merck Sharp & Dohme Corporation
$15
IDORSIA PHARMACEUTICALS US INC
$15
Ultragenyx Pharmaceutical Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$14
Mallinckrodt Hospital Products Inc.
$13
Abbott Laboratories
$13
Teva Pharmaceuticals USA, Inc.
$13
GE HEALTHCARE
$12
Avanir Pharmaceuticals, Inc.
$12
Top 3 companies account for 37.1% of total payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AREXVY · Actemra · Aimovig · BENLYSTA · BREZTRI · Bimzelx · COLOGUARD DNA CAPTURE REAGENTS · COSENTYX · Cimzia · Cologuard Collection Kit · Dayvigo · EMGALITY · EVENITY · Enbrel · FreeStyle Libre 2 · GARDASIL · GENERAL KIDNEY STONE DISEASE · HUMIRA · Heplisav-B · Humira · IDACIO · INJECTAFER · JANUVIA · KEVZARA · KINERET · KRYSTEXXA · Kerendia · Kineret · Korlym · LYRICA · Livalo · MOUNJARO · NUEDEXTA · OFEV · ORENCIA · Otezla · Otrexup · Ozempic · PENNSAID · PNEUMOVAX 23 · Prolia · QULIPTA · QUVIVIQ · REMICADE · REYVOW · RINVOQ · RYBELSUS · Rasuvo · Rinvoq · Rituxan · Rybelsus · SAPHNELO · SHINGRIX · SIMPONI · SIMPONI ARIA · SKYRIZI · SOLIQUA · STELARA · TALTZ · TAVNEOS · TOUJEO · TREMFYA · TRULICITY · TRUMENBA · Trulance · Tymlos · UBRELVY · VYEPTI · Vascepa · WatchPATONE · XELJANZ · XIFAXAN · XTANDI · Xultophy 100/3.6 · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $37 per 100 Medicare services performed
Geographic Context
Rheumatologists within 10 mi
3
Per 100K population
2.4
County median income
$64,809
Nearest hospital
LONGVIEW REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Erickstad is a mixed practice specialist, with above-average Medicare volume (top 29% in TX), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Erickstad experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Erickstad performed 13,020 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Erickstad receive payments from pharmaceutical companies?
Yes. Dr. Erickstad received a total of $10,908 from 52 companies across 755 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Erickstad's costs compare to other rheumatologists in Longview?
Dr. Erickstad's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Erickstad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Longview
Browse rheumatologists in Longview ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology